Trending News
News
News
Enzyme Inhibitor Boosts Immune System To Fight Antibiotic-Resistant Bacteria
Researchers from Johns Hopkins University discover an enzyme inhibitor that boosts the immune system to fight methicillin-resistant Staphylococcus aureus (MRSA) and other skin infections.
News
Using AI To Assess Biological Activity of Natural Products
Researchers have shown how artificial intelligence methods can be used to find new pharmaceutical applications for natural products.
News
New Synthetic Circuits Rely on Protein Interactions, Not Transcription and Translation
MIT synthetic biologists have now developed an alternative approach to designing synthetic circuits, which relies exclusively on fast, reversible protein-protein interactions. This means that there's no waiting for genes to be transcribed or translated into proteins, so circuits can be turned on much faster, within seconds.
News
Approach Identifies Drugs That Can "Glue" Proteins Together
Researchers have developed a novel drug screening method that can test the effectiveness of therapeutic molecules designed to "glue" proteins together.
News
Slowing Down Huntington’s Disease With Gene Therapy
In a new study on mice, Johns Hopkins Medicine researchers report that using MRI scans to measure blood volume in the brain can serve as a noninvasive way to potentially track the progress of gene editing therapies for early-stage Huntington’s disease, a neurodegenerative disorder that attacks brain cells.
News
Considerations When Designing COVID-19 Drug Trials
A new modeling study suggests that randomization, early patient enrollment and treatment initiation in clinical trials are key points to consider when identifying effective antiviral drugs against SARS-CoV-2.
News
iPSCs Used To Develop Cell Therapies for Colorectal Cancer
Researchers have demonstrated how induced pluripotent stem cells can be used to prepare potent adoptive cell transfer therapies for colorectal cancers.
News
Lipids in the Blood Linked to Drug Resistance in Schizophrenia
Researchers have found lipids in the plasma of people with schizophrenia, associated with lower symptom improvement over time during treatment.
News
Team Isolates Natural Catalysts for Better Drug Synthesis
Scientists have isolated a biocatalyst, known as 21R-citrinadin A, that could play a significant role in simplifying the development and manufacture of drugs.
News
mRNA Vaccine Recipients Are 91% Less Likely To Develop COVID-19
People who receive mRNA COVID-19 vaccines are up to 91 percent less likely to develop the disease than those who are unvaccinated, according to a new nationwide study of eight sites.
Advertisement